Inventor · disambiguated record
Douglas E. Brenneman
Also filed as: BRENNEMAN DOUGLAS · BRENNEMAN DOUGLAS E · BRENNEMAN DOUGLAS ERIC
16 granted patents·9 pending applications·335 citations·filing 1990–2022
94Inventor score
Files withUS HEALTH8UNIV RAMOT6KANNALIFE SCIENCES INC4SMITH GARRY ROBERT3US GOV HEALTH & HUMAN SERV2
Top patents by PatentIndex Score
25 records- 0188US8017578B2Orally active peptides that prevent cell damage and deathUS HEALTH·Filed 2008·Granted Sep 13, 2011·6 cites·6 claims
- 0287US7264947B2Activity dependent neurotrophic factor III (ADNF III)US HEALTH·Filed 2003·Granted Sep 4, 2007·26 cites·12 claims
- 0384US7384908B1Orally active peptides that prevent cell damage and deathUS HEALTH·Filed 2000·Granted Jun 10, 2008·17 cites·12 claims
- 0482US7863247B1Prevention of fetal alcohol syndrome and neuronal cell death with ADNF polypeptidesUNIV RAMOT·Filed 2000·Granted Jan 4, 2011·17 cites·21 claims
- 0582US6174862B1Neurotrophic peptides of activity dependent neurotrophic factorUNIV RAMOT·Filed 1994·Granted Jan 16, 2001·46 cites·35 claims
- 0681US7427598B2Post-natal administration of activity-dependent neurotrophic factor-derived polypeptides for enhancing learning and memoryUS HEALTH·Filed 2001·Granted Sep 23, 2008·15 cites·22 claims
- 0781US6613740B1Activity dependent neurotrophic factor III (ADNF III)UNIV RAMOT·Filed 1998·Granted Sep 2, 2003·49 cites·16 claims
- 0878US7427590B2Neurothrophic components of the ADNF I complexUS HEALTH·Filed 2002·Granted Sep 23, 2008·15 cites·16 claims
- 0976US5767240AActivity-dependent neurotrophic factorUS HEALTH·Filed 1992·Granted Jun 16, 1998·33 cites·10 claims
- 1074US5565424ASuperactive VIP antagonistsUNIV RAMOT·Filed 1994·Granted Oct 15, 1996·29 cites·26 claims
- 1171US5217953AVasoactive intestinal peptide antagonistUS HEALTH·Filed 1990·Granted Jun 8, 1993·30 cites·3 claims
- 1268US9611213B2Functionalized 1,3-benzene diols and their method of use for the treatment of hepatic encephalopathyKANNALIFE INC·Filed 2015·Granted Apr 4, 2017·2 cites·14 claims
- 1367US6933277B2Prevention of fetal alcohol syndrome and neuronal cell death with ADNF polypeptidesUNIV RAMOT·Filed 1999·Granted Aug 23, 2005·28 cites·16 claims
- 1466US6649411B2Methods of inhibiting cancer cells with ADNF III antisense oligonucleotidesUS HEALTH·Filed 1999·Granted Nov 18, 2003·22 cites·13 claims
- 1558US2009124543A1Activity dependent neurotrophic factor iii (adnf iii)US GOV HEALTH & HUMAN SERV·Filed 2007·Application pending·0 cites
- 1657US2009203615A1Use of activity dependent neurotrophic factor for enhancing learning and memory: pre-and post-natal administrationUS GOV HEALTH & HUMAN SERV·Filed 2008·Application pending·0 cites
- 1752US2009247457A1Neurotrophic components of the adnf i complexSECRETARY OF THE DEPTARTMENT O·Filed 2008·Application pending·0 cites
- 1850US2024131004A1Functionalized 1,3-benzene diols and their method of use for the treatment of inflammation and painKANNALIFE SCIENCES INC·Filed 2022·Application pending·0 cites
- 1945US2004235747A1Methods of treating and/or preventing autoimmune diseasesUNIV RAMOT·Filed 2003·Application pending·0 cites
- 2044US2022409578A1Functionalized 1,3-benzene diols and their method of use for the treatment of radiation dermatitis and other skin disordersKANNALIFE SCIENCES INC·Filed 2020·Application pending·0 cites
- 2143US10004722B2Method for treating hepatic encephalopathy or a disease associated with free radical mediate stress and oxidative stress with novel functionalized 1,3-benzene diolsKANNALIFE SCIENCES INC·Filed 2017·Granted Jun 26, 2018·0 cites·6 claims
- 2243US2022257620A1Use of certain phosphatidylcholines containing long chain polyunsaturated fatty acids as neuroprotective agentsKANNALIFE SCIENCES INC·Filed 2020·Application pending·0 cites
- 2341US8609849B1Hydroxylated sulfamides exhibiting neuroprotective action and their method of useSMITH GARRY ROBERT·Filed 2011·Granted Dec 17, 2013·0 cites·15 claims
- 2434US2013253022A1Novel fluorinated sulfamides exhibiting neuroprotective action and their method of useSMITH GARRY ROBERT·Filed 2011·Application pending·0 cites
- 2532US2012302546A1Novel sulfamides exhibiting neuroprotective action and methods for use thereofSMITH GARRY ROBERT·Filed 2011·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →